FDA Chief Counsel Is Assistant Attorney General Bradshaw
This article was originally published in The Pink Sheet Daily
Executive Summary
Bradshaw brings extensive high-level government service experience to the position as he permanently replaces former Chief Counsel Troy. Deputy Chief Counsel Masoudi has served in the position on an interim basis since Troy’s departure in November.
You may also be interested in...
FDA Chief Counsel Says Generic Firms Make Strong Case For Preemption
Generic product liability suits are on the rise, which could result in more generic drug makers arguing for federal preemption, Bradshaw says.
FDA Chief Counsel Says Generic Firms Make Strong Case For Preemption
Generic product liability suits are on the rise, which could result in more generic drug makers arguing for federal preemption, Bradshaw says.
FDA Chief Counsel Bradshaw's "Practical" Approach Applauded By Barr
Barr CEO Bruce Downey is praising FDA Chief Counsel Sheldon Bradshaw's attitude towards issues affecting the generic drug industry